Transdermal NSAID Matches Oral Celecoxib After Knee Replacement - Scorecard - MDSpire

Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

Randomized trial finds a topical anti-inflammatory patch provided similar pain relief, function, and safety as oral therapy during the first 6 weeks after surgery.

  • By

  • Doug Brunk

  • July 2, 2026

  • 4 min

Share

Clinical Scorecard: Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

At a Glance

CategoryDetail
ConditionPost-operative pain control after total knee arthroplasty
Key MechanismsTransdermal esflurbiprofen patch vs. oral celecoxib for pain management
Target PopulationPatients aged 50 years or older undergoing primary unilateral total knee arthroplasty for knee osteoarthritis
Care SettingSingle-center, prospective, randomized controlled trial

Key Highlights

  • Transdermal esflurbiprofen provided noninferior pain control compared to oral celecoxib.
  • Both treatments resulted in similar pain scores and functional recovery at 6 weeks.
  • No patients required rescue morphine in either treatment group.
  • Safety outcomes were comparable, with no serious adverse events reported.
  • Study limitations include small sample size and short treatment duration.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider transdermal esflurbiprofen as an alternative to oral celecoxib for post-operative pain control.

    Monitoring & Follow-up

    • Monitor kidney function at baseline, postoperative day 1, week 2, and week 6.

    Risks

    • Potential for unidentified rare side effects due to the study's limitations.

    Patient & Prescribing Data

    Patients aged 50 years or older undergoing total knee arthroplasty.

    Both transdermal esflurbiprofen and oral celecoxib were effective in managing post-operative pain.

    Clinical Best Practices

    • Implement multimodal pain management regimens including paracetamol and pregabalin.
    • Assess pain intensity using visual analog scale post-operatively.

    Related Resources & Content

    Original Source(s)

    Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

    • by Doug Brunk

    • July 2, 2026

    Related Content

    Culture Mismatch Common in Joint Infections

    Multicenter study suggests variability across centers and higher mismatch in certain clinical settings.

    The Loan Cap That Could Shrink the Doctor Pipeline

    New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

    Not All Hips Follow the Same Rules in THA

    Dynamic modeling suggested flatback deformity lowered target combined anteversion, while stiff pelvic mobility narrowed the acceptable range